Metabolic Surveillance for Those at High Risk for Developing Pancreatic Cancer
Gastroenterology
.
2021 Nov;161(5):1379-1380.
doi: 10.1053/j.gastro.2021.07.006.
Epub 2021 Jul 10.
Authors
Suresh T Chari
1
,
Dana K Andersen
2
Affiliations
1
MD Anderson Cancer Center, Houston, Texas.
2
Division of Digestive Disease and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Electronic address: dana.andersen@nih.gov.
PMID:
34256058
DOI:
10.1053/j.gastro.2021.07.006
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Pancreatic Neoplasms* / epidemiology